Objective: Food addiction (FA) construct was introduced to reflect abnormal eating patterns that resemble behavioural ones found in substance use disorders. FA has been barely explored in anorexia nervosa (AN). This study evaluated FA occurrence and associated factors in a sample of patients with AN, distinguishing between restrictive and binge–purging subtypes and focussing on the influence of FA in the crossover diagnosis between them.Method: A sample of 116 patients with AN admitted for treatment seeking at an Bellvitge Hospital Eating Disorders Unit were included (72 restrictive [AN‐R]; 44 binge‐purge AN [AN‐BP]), and eating‐related, personality and psychopathological variables were assessed. Most participants were women (92.2%), mean age 27.1 years old (SD = 10.5).Results: FA was more prevalent in patients with AN‐BP compared to the AN‐R group (75.0% and 54.2%, respectively). The patients with AN‐R FA+, presented more similar ED symptomatology, general psychopathology and personality traits, with the AN‐BP patients, than with the AN‐R FA‐.Conclusions: Patients with AN‐R FA+, exhibit more similarities with the AN‐BP subgroup than with the AN‐R FA‐. Thus, it is possible to hypothesise that the presence of FA might be an indicator of the possible crossover from AN‐R to AN‐BP.

Objective: Regular massages can be an instrument to help the body recover and maintain health. The growing trend toward musculoskeletal personal health care is accompanied by the use of natural products. When deciding between topical products, their characteristics become crucial, especially in sensitive skin where treatments are applied routinely. This study evaluates for the first time the cosmetic and application properties of Physiorelax, a natural musculoskeletal health care product suitable for muscle and ligament massage, compared to Fisiocrem. Methods: This is a sensory panel methodology, using a mixed descriptive approach (qualitative/quantitative). Twenty panelists trained in quantitative sensory analysis since 2018 evaluated the two products. Product presentation was randomized and blinded. Cosmetic results are presented as percent agreement among panelists and application aspects as quantitative scores. Results: Both products show a comparable sensory profile, in terms of application properties: shape integrity, firmness, moisture/grease balance, spreadability, low tack afterfeel, and residue. However, in terms of an overall preference for product, 90% of panelists liked Pshysiorelax, against 70% for Fisiocrem. An additional 10% of panelists disliked Fisiocrem over Pshysiorelax (chi‐square = 12.5, p = 0.002). The results should be interpreted considering the inherent limitations of the panel design itself. Future studies could assess the preference of use of the product by daily care professionals and the general population. Conclusion: Considering the panelists' general preference for Physiorelax, and the addition in this product of extra natural ingredients preserving skin care, Physiorelax seems a very good candidate for daily use for musculoskeletal health care and as a massage cream for muscles and ligaments in personal care.

Massage relieves stress and anxiety, but also helps to reduce musculoskeletal problems, decreasing tension, in all stages of life. For pediatric use, organoleptic properties, cosmetic safety and user acceptability of topical products are important given the higher frequency of irritative or allergic episodes in young skin. We evaluate for the first time the comprehensive cosmetic performance of Physiorelax Forte Plus natural formulation in cream, spray and roll-on applied regularly in healthy and active children/adolescents. 210 healthy volunteers were included (150 adults with sensitive skin and 60 children and adolescents [6–16 years]). This three-part, sequential, observational, non-comparative pilot design monitored user experience under real-world conditions: (I) Open-label testing to assess skin compatibility in adults (N = 60); (II) In-use testing in adults for cosmetic acceptability and safety over 14 days (N = 90); (III) In-use testing in children/adolescents for 14 days (N = 60). Outcomes were dermatological assessments for tolerability and user (and/or parents/caregiver(s)-reported) satisfaction/acceptability and perceived benefits. No control group or objective efficacy measures were included. Among pediatric participants, no cutaneous reactions were observed at application sites after 14 days of use. Proxy reporting about consumer satisfaction and acceptability for the range were generally high. Principal component analysis revealed a clear three-cluster structure (sensory, functional, practicality), with roll-on driving the strongest differentiation across items and spray aligning most closely with sensory attributes, while cream showed an intermediate functional profile. The Physiorelax Forte Plus range demonstrated a favorable cosmetic safety profile and consumer acceptability in pediatric use under real-world conditions. Findings are limited by the observational, unblinded design, absence of a control group, and reliance on subjectively reported outcomes; no clinical or pharmaceutical claims are implied. Future controlled studies incorporating objective dermatologic endpoints, benchmark products, and direct child/adolescent reporting are warranted.

Products with CBD are gaining ground in the cosmetic and massage cream market. However, the growing trend towards natural and effective pain relief and CBD-containing creams underscores the importance of making a well-informed product choice. By examining the organoleptic properties of these creams, we can obtain valuable insights into their performance and acceptance, contributing to a more informed market. To investigate the sensory profile of Physiorelax® CBD compared to three other CBD-infused topical massage creams, all aimed at providing natural relief for muscle and joint pain. An initial group of 20 panellists trained in sensory panel methodology since 2018 was convened to evaluate the four products. The presentation of the creams was randomised and blinded. Organoleptic characteristics were assessed using quantitative scores. The four creams exhibited a comparable sensory profile overall, with Physiorelax® CBD standing out in certain aspects related to appearance and pick-up characteristics. Physiorelax® CBD showed higher scores compared to Fisiocrem® Cannabis in integrity of shape (*P=0.006; *P=0.003 after 10 seconds), firmness (*P=0.006), and stickiness (*P=0.033). It also differs in initial glossiness (in terms of visible shine observed in the cream before application) compared to Cannaben® (*P=0.005), Alivium® CBD (*P<0.005), and Fisiocrem® Cannabis (*P=0.02), with a median of 70 (Alivium® CBD median of 50; Cannaben® and Fisiocrem® Cannabis median of 75). Physiorelax® CBD excels in some sensory characteristics of application compared to the other topical products tested. With a 1% CBD concentration and a blend of anti-inflammatory and analgesic natural ingredients, Physiorelax® CBD stands out as a strong option from a sensory and formulation perspective, showing properties that may be of interest for topical musculoskeletal products. However, no conclusions on clinical effectiveness can be inferred from this study.